Author

Chandrika Gowda Behura

Pennsylvania State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Hannah ValensiiD· 3 shared Marudhu Pandiyan ShanmugamiD· 3 shared Rajesh Rajaiah· 3 shared Upendarrao GollaiD· 3 shared Yasin UzuniD· 3 shared Katherine Mercer· 2 shared Muhammad DaniyaliD· 2 shared Sinisa DovatiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Hannah ValensiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsbioRxivPreprintApr 15, 2026

Lineage-specific CK2α deletion reshapes the transcriptome of hematopoietic stem cells toward an immune-primed state

Hannah Valensi, Rajesh Rajaiah, Marudhu Pandiyan Shanmugam…·Yasin Uzun

This study shows that deleting CK2α in hematopoietic stem cells (HSCs) alters their transcriptome toward an immune-primed state, with tissue-specific effects on inflammatory and immune-related genes.

DOI 10.64898/2026.04.10.717787

mousescRNA-seq

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintDec 26, 2025

CK2 inhibitor, CX-4945, enhances BH3 priming and promotes apoptosis of venetoclax-resistant AML by targeting antiapoptotic proteins

Muhammad Daniyal, Rajesh Rajaiah, Upendarrao Golla…·Chandrika Gowda Behura

DOI 10.64898/2025.12.24.696284

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 24, 2025

CK2 inhibitor CX-4945 targets EWS-FLI1 signaling network and shows therapeutic efficacy in metastatic mouse models of Ewing Sarcoma

Muhammad Daniyal, Rajesh Rajaiah, Upendarrao Golla…·Chandrika Gowda Behura

This study shows that CK2 inhibitor CX-4945 targets EWS-FLI1 and reduces tumor growth and metastasis in Ewing Sarcoma models.

DOI 10.1101/2025.09.24.677357

mousebulk RNA-seq

𝕏 PostBluesky